Summary of VigiBase total and fatal reports for cardioselective β1-blockers with asthma or bronchospasm as reported suspected adverse reactions from start to December 2019
| Cardioselective β1-blockers | Reactions coded as asthma | Reactions coded as bronchospasm | ||
| Total | Of which were fatal | Total | Of which were fatal | |
| Metoprolol | 286 | 4 | 322 | 6 |
| Atenolol | 141 | 1 | 385 | 3 |
| Bisoprolol | 95 | 0 | 108 | 1 |
| Nebivolol | 29 | 0 | 32 | 0 |
| Betaxolol | 18 | 0 | 86 | 0 |
| Acebutolol | 5 | 1 | 30 | 0 |
| Celiprolol | 6 | 0 | 41 | 1 |
| Landiolol | 1 | 0 | 0 | 0 |
| Esmolol | 1 | 0 | 11 | 1 |
| Esatenolol | 1 | 0 | 0 | 0 |